Jens Malte Baron

Summary

Affiliation: RWTH Aachen
Country: Germany

Publications

  1. ncbi From the clinic to genome: a way to new drugs and therapy? Workshop of the Bundesverband der Pharmazeutischen Industrie eV (BPI), Berlin, Germany
    Jens Malte Baron
    Department of Dermatology, University Clinic RWTH Aachen, Germany
    Skin Pharmacol Appl Skin Physiol 15:275-6. 2002
  2. ncbi [Array technology in skin pharmacology and allergology]
    J M Baron
    Hautklinik, Universitätsklinikum der RWTH Aachen
    Hautarzt 54:315-20. 2003
  3. ncbi Evidence-based staging system for malignant melanoma: is new necessarily better?
    Jens M Baron
    Department of Dermatology and Allergology, University Hospital RWTH Aachen, Aachen D 52074, Germany
    Lancet 364:395-6. 2004
  4. ncbi Expression of multiple cytochrome p450 enzymes and multidrug resistance-associated transport proteins in human skin keratinocytes
    J M Baron
    Department of Dermatology, Hospital, RWTH Aachen, Germany
    J Invest Dermatol 116:541-8. 2001
  5. ncbi Drug metabolism in the skin
    J M Baron
    Department of Dermatology, University Hospital, RWTH Aachen, Aachen, Germany
    Curr Opin Allergy Clin Immunol 1:287-91. 2001
  6. ncbi Retinoic acid and its 4-oxo metabolites are functionally active in human skin cells in vitro
    Jens M Baron
    Department of Dermatology and Allergology, University Hospital of the RWTH, Aachen, Germany
    J Invest Dermatol 125:143-53. 2005
  7. ncbi Expression and function of cytochrome p450-dependent enzymes in human skin cells
    J M Baron
    Department of Dermatology and Allergology, University Hospital, RWTH Aachen University, Pauwelsstrabe 30, D 52074 Aachen, Germany
    Curr Med Chem 15:2258-64. 2008
  8. ncbi Research in practice: the second barrier of the human skin
    Jens Malte Baron
    Department of Dermatology, University Hospital, Aachen University of Technology RWTH, Aachen, Germany
    J Dtsch Dermatol Ges 8:155-8. 2010

Detail Information

Publications8

  1. ncbi From the clinic to genome: a way to new drugs and therapy? Workshop of the Bundesverband der Pharmazeutischen Industrie eV (BPI), Berlin, Germany
    Jens Malte Baron
    Department of Dermatology, University Clinic RWTH Aachen, Germany
    Skin Pharmacol Appl Skin Physiol 15:275-6. 2002
  2. ncbi [Array technology in skin pharmacology and allergology]
    J M Baron
    Hautklinik, Universitätsklinikum der RWTH Aachen
    Hautarzt 54:315-20. 2003
    ....
  3. ncbi Evidence-based staging system for malignant melanoma: is new necessarily better?
    Jens M Baron
    Department of Dermatology and Allergology, University Hospital RWTH Aachen, Aachen D 52074, Germany
    Lancet 364:395-6. 2004
  4. ncbi Expression of multiple cytochrome p450 enzymes and multidrug resistance-associated transport proteins in human skin keratinocytes
    J M Baron
    Department of Dermatology, Hospital, RWTH Aachen, Germany
    J Invest Dermatol 116:541-8. 2001
    ....
  5. ncbi Drug metabolism in the skin
    J M Baron
    Department of Dermatology, University Hospital, RWTH Aachen, Aachen, Germany
    Curr Opin Allergy Clin Immunol 1:287-91. 2001
    ....
  6. ncbi Retinoic acid and its 4-oxo metabolites are functionally active in human skin cells in vitro
    Jens M Baron
    Department of Dermatology and Allergology, University Hospital of the RWTH, Aachen, Germany
    J Invest Dermatol 125:143-53. 2005
    ....
  7. ncbi Expression and function of cytochrome p450-dependent enzymes in human skin cells
    J M Baron
    Department of Dermatology and Allergology, University Hospital, RWTH Aachen University, Pauwelsstrabe 30, D 52074 Aachen, Germany
    Curr Med Chem 15:2258-64. 2008
    ..Therefore knowledge of skin-specific CYP expression and function is a prerequisite for pharmacological studies of the skin...
  8. ncbi Research in practice: the second barrier of the human skin
    Jens Malte Baron
    Department of Dermatology, University Hospital, Aachen University of Technology RWTH, Aachen, Germany
    J Dtsch Dermatol Ges 8:155-8. 2010
    ..Inhibition of this metabolism mediated activation of prohaptens and stimulation of the active elimination of contact allergens from skin cells could represent novel mechanisms improving the established tools for skin protection...